Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/c27b7cff-4087-43d6-b651-c86cb1e4bab3/

AHCO

Adapthealth Corp
Chart
$9.89
Latest Week 2026-06-05
HealthcareMedical DevicesSMALL
Snapshot 2026-06-07 · 0.0w · Fresh
0.83
OS Score
87.0%
Value
26.0%
Quality
67.0%
Momentum
#41.00000000
TV Rank
5/9
F-Score
0.476
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
6 of 23 passing
★
OS Composite
OS 0.830
↗
Trending Value
#41.00000000
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
VC2 8.00000000
📐
EBITDA/EV
15.1%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 27%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 87th
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
87.0%ile
P/S
0.5×
P/B
0.9×
FCF Yield
0.318
EBITDA/EV
0.151
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
6.00000000
/100 — 1=cheapest
VC2 (Trending Value)
8.00000000
/100
VC3 (Buyback)
8.00000000
/100
FCF yield of 31.8% is strong — the business generates significant free cash relative to price. VC2 score of 8.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
26.0%ile
ROE
-0.053
ROA
-0.018
Net Margin
-0.028
Op Margin
0.026
GPA
0.035
D/E
1.93
Current
0.92
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.088
Stability
64.955
lower=better
Accruals
-0.154
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
67.0%ile
6M Return
5.0%
12M Return
11.1%
12-1 Mom
27.0%
Risk-Adj
0.66
Vol 252d
40.8%
Vol 60d
94.1%
↑ Expanding
Max DD 12M
-24.9%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 27% is very strong — a clear uptrend. Near-term vol (94%) is expanding vs long-term (41%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.83
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
93.8%
Sector Quality %ile
9.2%
P/B z-score
-0.34
Sector Avg OS
63.2%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Cheap for a Reason?
Looks cheap (87th value) but weak quality (26th). Classic value trap risk.
Volatility Expanding
60-day vol (94%) significantly exceeds 252-day (41%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
76.0% avg (5 factors)
Quality
F
25.6% avg (8 factors)
Momentum
C
50.0% avg (4 factors)
Risk
C
48.6% avg (1 factors)
Deep value territory, but quality is concerning. This is either a turnaround opportunity or a value trap — the F-Score and accruals ratio will be key differentiators.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.830—1—
Value %ile0.870—1—
Quality %ile0.260—1—
Momentum %ile0.670—0—
F-Score5.000—0—
Confidence0.909—1—
Volatility0.408—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
0.47
Price / Book
0.89
Price / Cash Flow
2.24
FCF Yield
31.8%
EBITDA / EV
15.1%
Sales Yield (1/P·S)
0.9018
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-5.3%
Return on Assets
-1.8%
Net Margin
-2.8%
Operating Margin
2.6%
Gross Profit / Assets
Novy-Marx GPA
3.5%
Debt / Equity
1.93
Current Ratio
0.92
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.154
MomentumPrice trend strength over different horizons
6M Return
5.0%
12M Return
11.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
27.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.66
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
8.8%
Earnings Stability (CV)
Lower = more stable
64.955
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
6
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
8
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
8
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
41
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity